Skip to main content

Gilead’s Patent Loss to Merck Started With a Broken Friendship

Peter Corless, a Member in the Boston Mintz office and experienced intellectual property lawyer, is featured in this Bloomberg article discussing Gilead Science’s patent loss to Merck & Co. The article notes that if Gilead if forced to pay Merck more than $2.5B in royalties it could be due to the alleged broken friendship between two scientists.